135 related articles for article (PubMed ID: 29182642)
1. Elevated N-telopeptide as a potential diagnostic marker for bone metastasis in lung cancer: A meta-analysis.
Liu B; Zhao Y; Yuan J; Zeng L; Sun R; Meng X; Yang S
PLoS One; 2017; 12(11):e0187860. PubMed ID: 29182642
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of urinary and serum cross-linked N-telopeptide of type I collagen (NTx) for diagnosis of bone metastasis in patients with lung cancer.
Tamiya M; Tokunaga S; Okada H; Suzuki H; Kobayashi M; Sasada S; Okamoto N; Morishita N; Matsuura Y; Miyamoto N; Hattori M; Taira K; Daga H; Takeda K; Hirashima T
Clin Lung Cancer; 2013 Jul; 14(4):364-9. PubMed ID: 23276824
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of the serum cross-linked N-telopeptide of type I collagen as a marker of bone metastasis from lung cancer.
Tamiya M; Suzuki H; Kobayashi M; Sasada S; Okamoto N; Morishita N; Yasue T; Matsuura Y; Hirashima T; Kawase I
Med Oncol; 2012 Mar; 29(1):215-8. PubMed ID: 21258879
[TBL] [Abstract][Full Text] [Related]
4. Serum cross-linked N-telopeptide of type I collagen as a potential diagnostic marker for bone metastasis in lung cancer: An updated meta-analysis.
Wang H; Hong M; Ding L; Song B
Thorac Cancer; 2023 Mar; 14(9):787-793. PubMed ID: 36717764
[TBL] [Abstract][Full Text] [Related]
5. A meta-analysis survey of appropriate bone turnover markers in the detection of bone metastasis in lung cancer.
Huang J; Gu T; Ying J
Int J Clin Oncol; 2017 Dec; 22(6):1015-1025. PubMed ID: 28677013
[TBL] [Abstract][Full Text] [Related]
6. Usefulness of bone metabolic markers in the diagnosis of bone metastasis from lung cancer.
Chung JH; Park MS; Kim YS; Chang J; Kim JH; Kim SK; Kim SK
Yonsei Med J; 2005 Jun; 46(3):388-93. PubMed ID: 15988811
[TBL] [Abstract][Full Text] [Related]
7. Serum cross-linked N-telopeptide of type I collagen for the diagnosis of bone metastases from solid tumours in the Chinese population: Meta-analysis.
Zhang Y; Yi M; Cao J; Hou C; Zhou Y; Zhong Y
J Int Med Res; 2016 Apr; 44(2):192-200. PubMed ID: 26857861
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of bone-turnover metabolites in the diagnosis of bone metastases in patients with lung carcinoma.
Izumi M; Nakanishi Y; Takayama K; Kimotsuki K; Inoue K; Wataya H; Minami T; Hara N
Cancer; 2001 Apr; 91(8):1487-93. PubMed ID: 11301396
[TBL] [Abstract][Full Text] [Related]
9. Increased serum amyloid A as potential diagnostic marker for lung cancer: a meta-analysis based on nine studies.
Biaoxue R; Hua L; Wenlong G; Shuanying Y
BMC Cancer; 2016 Nov; 16(1):836. PubMed ID: 27809798
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Bone Metastasis Using Serial Measurements of Serum N-Telopeptides of Type I Collagen in Patients with Lung Cancer: A Prospective Study.
Tamiya M; Tokunaga S; Okada H; Suzuki H; Sasada S; Okamoto N; Morishita N; Shiroyama T; Otsuka T; Miyamoto N; Taira K; Daga H; Takeda K; Hirashima T
Anticancer Res; 2015 Jul; 35(7):3987-93. PubMed ID: 26124346
[TBL] [Abstract][Full Text] [Related]
11. The clinical importance of bone metabolic markers in detecting bone metastasis of lung cancer.
Bayrak SB; Ceylan E; Serter M; Karadağ F; Demir E; Çildağ O
Int J Clin Oncol; 2012 Apr; 17(2):112-8. PubMed ID: 21691728
[TBL] [Abstract][Full Text] [Related]
12. Serum N-telopeptide of type I collagen and bone alkaline phosphatase and their relationship in patients with non-small cell lung carcinoma and bone metastases. Preliminary results.
Lumachi F; Marino F; Fanti G; Chiara GB; Basso SM
Anticancer Res; 2011 Nov; 31(11):3879-81. PubMed ID: 22110213
[TBL] [Abstract][Full Text] [Related]
13. [Comparative study of bone resorption markers for the diagnosis of bone metastasis in lung cancer].
Nakamura H; Oishi S; Yagyu H; Morisako T; Kishi K; Tsuchida F; Adachi H; Sarashina G; Sudoh A; Hashimoto T; Matsuoka T
Nihon Kokyuki Gakkai Zasshi; 2002 May; 40(5):355-9. PubMed ID: 12166253
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of the serum crosslinked N-telopeptide of type I collagen as a prognostic marker for non-small-cell lung cancer.
Tamiya M; Kobayashi M; Morimura O; Yasue T; Nakasuji T; Satomu M; Kohei O; Takayuki S; Morishita N; Suzuki H; Sasada S; Okamoto N; Hirashima T; Kawase I
Clin Lung Cancer; 2013 Jan; 14(1):50-4. PubMed ID: 22609050
[TBL] [Abstract][Full Text] [Related]
15. Comparison of serum bone resorption markers in the diagnosis of skeletal metastasis.
Koizumi M; Takahashi S; Ogata E
Anticancer Res; 2003; 23(5b):4095-9. PubMed ID: 14666607
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of serum BAP, TRACP 5b and ICTP as bone metabolic markers for bone metastasis screening in lung cancer patients.
Tang C; Liu Y; Qin H; Li X; Guo W; Li J; Wang W; Qu L; Hu H; Xu C; Zheng L; Huang Y; Liu B; Gao H; Halleen JM; Liu X
Clin Chim Acta; 2013 Nov; 426():102-7. PubMed ID: 24055775
[TBL] [Abstract][Full Text] [Related]
17. Correlation of urine type I collagen-cross-linked N telopeptide levels with bone scintigraphic results in prostate cancer patients.
Fukumitsu N; Uchiyama M; Mori Y; Yanada S; Hatano T; Igarashi H; Kishimoto K; Nakada J; Yoshihiro A; Harada J
Metabolism; 2002 Jul; 51(7):814-8. PubMed ID: 12077723
[TBL] [Abstract][Full Text] [Related]
18. Baseline serum NTx levels are prognostic in metastatic breast cancer patients with bone-only metastasis.
Ali SM; Demers LM; Leitzel K; Harvey HA; Clemens D; Mallinak N; Engle L; Chinchilli V; Costa L; Brady C; Seaman J; Lipton A
Ann Oncol; 2004 Mar; 15(3):455-9. PubMed ID: 14998848
[TBL] [Abstract][Full Text] [Related]
19. Markers of bone metastases in breast and lung cancers.
Bilgin E; Yasasever V; Soydinc HO; Yasasever CT; Ozturk N; Duranyildiz D
Asian Pac J Cancer Prev; 2012; 13(9):4331-4. PubMed ID: 23167338
[TBL] [Abstract][Full Text] [Related]
20. [Clinical usefulness of serum pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP) for diagnosis of bone metastasis in patients with primary lung cancer].
Yokoyama T; Yamamoto M; Shima K; Suzuki K; Sako C; Ito G; Kume M; Maeda M
Nihon Kokyuki Gakkai Zasshi; 2003 Dec; 41(12):857-60. PubMed ID: 14727545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
